Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SCD | O00767 | 8/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL17254518 | 0.99 | KDM4E (0.42) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL14377117 | 0.89 | KDM4E (0.44) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL15908041 | 0.88 | MEN1 (0.43) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL16476452 | 0.86 | KDM4E (0.42) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL15908087 | 0.83 | KDM4E (0.40) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL19415820 | 0.82 | KDM4E (0.41) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL15908096 | 0.82 | KDM4E (0.41) | KDM4EMEN1KMT2AUSP2MAPT | |
| Bromide SCHEMBL15901676 | 0.81 | KDM4E (0.40) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL22653180 | 0.81 | BRD4 (0.42) | KDM4EMEN1KMT2AUSP2MAPT | |
| SCHEMBL16476446 | 0.81 | KDM4E (0.43) | KDM4EMEN1KMT2AUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723743-B1 | 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | TRIOPTOTEC GMBH (DE) | 2019-08-14 | — | — | EP | disclosed |
| WO-2017167992-A1 | PHOTOSENSITIVE DISPERSION AND USE THEREOF | UNIVERSITÄT REGENSBURG (DE) | 2017-10-05 | — | — | WO | disclosed |
| US-9185913-B2 | 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof | TRIOPTOTEC GMBH (DE) | 2015-11-17 | — | — | US | disclosed |
| US-20140200220-A1 | 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | TRIOPTOTEC GMBH (DE) | 2014-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140200220-A1 | 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | DHPS, DOHH, DPYD | KDM4E 495/4885MEN1 2099/4885KMT2A 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.